In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
about
The physiology of cardiovascular disease and innovative liposomal platforms for therapyNanotechnology in diagnosis and treatment of coronary artery disease.Drug delivery systems, CNS protection, and the blood brain barrierPreparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombusMultiscale observation of biological interactions of nanocarriers: from nano to macro.Insights into atherosclerosis using nanotechnologyRAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.Phage-display-guided nanocarrier targeting to atheroprone vasculature.Conserved Amblyomma americanum tick Serpin19, an inhibitor of blood clotting factors Xa and XIa, trypsin and plasmin, has anti-haemostatic functions.Synthetic Strategies for Engineering Intravenous Hemostats.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.A platelet-mimetic paradigm for metastasis-targeted nanomedicine platformsNanotechnology in interventional cardiology.Fibrinolytic PLGA nanoparticles for slow clot lysis within abdominal aortic aneurysms attenuate proteolytic loss of vascular elastic matrix.Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion.Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.Platelet integrins exhibit anisotropic mechanosensing and harness piconewton forces to mediate platelet aggregation.Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs
P2860
Q27002949-6CC42348-E783-4CD1-A48E-7605E71AEF91Q30362371-605C80BE-6398-4360-A11B-9A3774F2AC6AQ30432845-853ED09D-787B-4A7D-8523-8CE0B9D35929Q30448359-ED026B89-B340-4FE3-A2B1-183E024AFB65Q30474384-ABB87487-BAD8-42FE-8E83-FE755F5731A3Q33824820-DB7FF16E-0E6F-4F78-B25A-C903DB668BC6Q34044872-634C8BE5-3C27-4180-8D81-C6DB76E85C16Q35576617-72D2AE21-520F-4C9E-A66C-EB3486BE96A9Q35812375-88660992-2D92-45E6-9E86-ED8760B3DC98Q35858739-DB783EA7-B881-46C9-B70A-373BFE13AC65Q36913594-2119E526-B462-4952-A166-F41D1BE1DB00Q36949458-EBC10BCD-6BFC-4320-925A-F356FAD0817BQ37900267-0EEF467C-432C-4AD7-B9A1-702C10E616F0Q38933647-4C014F75-A35D-4451-BA43-4881FEA94B78Q41157466-50448F1C-293A-4CCF-A8C6-2E2B07754FDDQ41674171-623F4A60-3AFA-45F7-88F2-6D20A983FAEDQ47226792-19050AA0-B5EE-4171-880D-EE0E900D7FACQ58910462-A177DCB5-B40D-4528-8511-2128095C3B38
P2860
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
@en
type
label
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
@en
prefLabel
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
@en
P2093
P2860
P356
P1476
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
@en
P2093
Anirban Sen Gupta
Rekha Srinivasan
Roger E Marchant
P2860
P304
P356
10.1002/JBM.A.32549
P577
2010-06-01T00:00:00Z